Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.

Thyssen JP, de Bruin-Weller MS, Paller AS, Leshem YA, Vestergaard C, Deleuran M, Drucker AM, Foelster-Holst R, Traidl-Hoffmann C, Eyerich K, Taieb A, Su JC, Bieber T, Cork MJ, Eichenfield LF, Guttman-Yassky E, Wollenberg A.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1224-1231. doi: 10.1111/jdv.15608. Epub 2019 May 6.

2.

Psoriasis Pathogenesis: Keratinocytes Are Back in the Spotlight.

Garzorz-Stark N, Eyerich K.

J Invest Dermatol. 2019 May;139(5):995-996. doi: 10.1016/j.jid.2019.01.026. Epub 2019 Apr 19.

PMID:
31010530
3.

Continued treatment with secukinumab is associated with high retention or regain of response.

Augustin M, Thaci D, Eyerich K, Pinter A, Radtke M, Lauffer F, Mrowietz U, Gerdes S, Pariser D, Lebwohl M, Sieder C, Melzer N, Reich K.

Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.17991. [Epub ahead of print]

PMID:
30972746
4.

Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study.

Gasslitter I, Kirsten N, Augustin M, Torz K, Mrowietz U, Eyerich K, Puig L, Hoetzenecker W, Schütz-Bergmayr M, Weger W, Wolf P, Reider N, Ratzinger G, Papageorgiou K, Meier TO, Maul JT, Anzengruber F, Navarini AA.

Arch Dermatol Res. 2019 Jul;311(5):421-424. doi: 10.1007/s00403-019-01907-y. Epub 2019 Mar 16.

PMID:
30879102
5.

Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment.

Matthias J, Maul J, Noster R, Meinl H, Chao YY, Gerstenberg H, Jeschke F, Gasparoni G, Welle A, Walter J, Nordström K, Eberhardt K, Renisch D, Donakonda S, Knolle P, Soll D, Grabbe S, Garzorz-Stark N, Eyerich K, Biedermann T, Baumjohann D, Zielinski CE.

Sci Transl Med. 2019 Feb 20;11(480). pii: eaau0683. doi: 10.1126/scitranslmed.aau0683.

PMID:
30787167
6.

Variable response to low-dose naltrexone in patients with Darier disease: a case series.

Boehmer D, Eyerich K, Darsow U, Biedermann T, Zink A.

J Eur Acad Dermatol Venereol. 2019 May;33(5):950-953. doi: 10.1111/jdv.15457. Epub 2019 Mar 5.

PMID:
30712317
7.

[Personalized medicine].

Eyerich K, Tüting T.

Hautarzt. 2019 Jan;70(1):4. doi: 10.1007/s00105-018-4331-2. German. No abstract available.

PMID:
30635691
8.

[Personalized medicine in the field of inflammatory skin diseases].

Garzorz-Stark N, Eyerich K.

Hautarzt. 2019 Jan;70(1):15-20. doi: 10.1007/s00105-018-4310-7. Review. German.

PMID:
30456602
9.

Non-invasive imaging in dermatology and the unique potential of raster-scan optoacoustic mesoscopy.

Hindelang B, Aguirre J, Schwarz M, Berezhnoi A, Eyerich K, Ntziachristos V, Biedermann T, Darsow U.

J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1051-1061. doi: 10.1111/jdv.15342. Epub 2019 Apr 5. Review.

10.

Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council.

Eyerich K, Brown SJ, Perez White BE, Tanaka RJ, Bissonette R, Dhar S, Bieber T, Hijnen DJ, Guttman-Yassky E, Irvine A, Thyssen JP, Vestergaard C, Werfel T, Wollenberg A, Paller AS, Reynolds NJ.

J Allergy Clin Immunol. 2019 Jan;143(1):36-45. doi: 10.1016/j.jaci.2018.10.033. Epub 2018 Nov 7.

11.

Human exposure to airborne pollen and relationships with symptoms and immune responses: Indoors versus outdoors, circadian patterns and meteorological effects in alpine and urban environments.

Damialis A, Häring F, Gökkaya M, Rauer D, Reiger M, Bezold S, Bounas-Pyrros N, Eyerich K, Todorova A, Hammel G, Gilles S, Traidl-Hoffmann C.

Sci Total Environ. 2019 Feb 25;653:190-199. doi: 10.1016/j.scitotenv.2018.10.366. Epub 2018 Oct 30.

PMID:
30408667
12.

[46/f with itchy skin lesions in seborrheic areas : Preparation for the specialist examination: part 7].

Boehmer D, Eyerich K.

Hautarzt. 2018 Nov;69(Suppl 2):105-108. doi: 10.1007/s00105-018-4252-0. German. No abstract available.

PMID:
30374553
13.

Muskelhypertrophie und Onychodystrophie.

Mattjie RA, Kelenjian S, Haas T, Biedermann T, Eyerich K.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1278-1281. doi: 10.1111/ddg.13659_g. No abstract available.

PMID:
30300494
14.

Muscle hypertrophy and onychodystrophy.

Mattjie RA, Kelenjian S, Haas T, Biedermann T, Eyerich K.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1278-1281. doi: 10.1111/ddg.13659. No abstract available.

PMID:
30300485
15.

Atopisches Ekzem: die Basis nicht vergessen!

Eyerich K.

J Dtsch Dermatol Ges. 2018 Aug;16(8):963-964. doi: 10.1111/ddg.13588. No abstract available.

PMID:
30117706
16.

Relations between epidermal barrier dysregulation and Staphylococcus species-dominated microbiome dysbiosis in patients with atopic dermatitis.

Altunbulakli C, Reiger M, Neumann AU, Garzorz-Stark N, Fleming M, Huelpuesch C, Castro-Giner F, Eyerich K, Akdis CA, Traidl-Hoffmann C.

J Allergy Clin Immunol. 2018 Nov;142(5):1643-1647.e12. doi: 10.1016/j.jaci.2018.07.005. Epub 2018 Jul 24. No abstract available.

PMID:
30048670
17.

Ixekizumab gegen die Acrodermatitis continua.

Pilz AC, Roenneberg S, Biedermann T, Eyerich K.

J Dtsch Dermatol Ges. 2018 Jul;16(7):907-910. doi: 10.1111/ddg.13568_g. No abstract available.

PMID:
29989369
18.

Assessing nailfold microvascular structure with ultra-wideband raster-scan optoacoustic mesoscopy.

Aguirre J, Hindelang B, Berezhnoi A, Darsow U, Lauffer F, Eyerich K, Biedermann T, Ntziachristos V.

Photoacoustics. 2018 Feb 21;10:31-37. doi: 10.1016/j.pacs.2018.02.002. eCollection 2018 Jun.

19.

45th meeting of the Arbeitsgemeinschaft Dermatologische Forschung.

Loser K, Eming R, Eyerich K, Gebhardt C, Ludwig R, Baghin V, Baurecht H, Forsthuber A, Glodde N, Schmidt E, Schmidt T, Shridhar N, Simon B, Gaffal E.

Exp Dermatol. 2018 Jul;27(7):798-802. doi: 10.1111/exd.13695. No abstract available.

PMID:
29953698
20.

Ixekizumab for acrodermatitis continua.

Pilz AC, Roenneberg S, Biedermann T, Eyerich K.

J Dtsch Dermatol Ges. 2018 Jul;16(7):907-910. doi: 10.1111/ddg.13568. Epub 2018 Jun 21. No abstract available.

PMID:
29927543
21.

Is the humoral immunity dispensable for the pathogenesis of psoriasis?

Thomas J, Küpper M, Batra R, Jargosch M, Atenhan A, Baghin V, Krause L, Lauffer F, Biedermann T, Theis FJ, Eyerich K, Eyerich S, Garzorz-Stark N.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):115-122. doi: 10.1111/jdv.15101. Epub 2018 Jul 2.

PMID:
29856508
22.

Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.

Boehner A, Navarini AA, Eyerich K.

Exp Dermatol. 2018 Oct;27(10):1067-1077. doi: 10.1111/exd.13699. Epub 2018 Jul 20. Review.

PMID:
29852521
23.

Cutaneous Barriers and Skin Immunity: Differentiating A Connected Network.

Eyerich S, Eyerich K, Traidl-Hoffmann C, Biedermann T.

Trends Immunol. 2018 Apr;39(4):315-327. doi: 10.1016/j.it.2018.02.004. Epub 2018 Mar 15. Review.

PMID:
29551468
24.

Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis.

Lauffer F, Jargosch M, Krause L, Garzorz-Stark N, Franz R, Roenneberg S, Böhner A, Mueller NS, Theis FJ, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K.

J Invest Dermatol. 2018 Aug;138(8):1785-1794. doi: 10.1016/j.jid.2018.02.034. Epub 2018 Mar 9.

PMID:
29526761
25.

Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.

Vandeghinste N, Klattig J, Jagerschmidt C, Lavazais S, Marsais F, Haas JD, Auberval M, Lauffer F, Moran T, Ongenaert M, Van Balen M, Dupont S, Lepescheux L, Garcia T, Härtle S, Eyerich K, Fallon PG, Brys R, Steidl S.

J Invest Dermatol. 2018 Jul;138(7):1555-1563. doi: 10.1016/j.jid.2018.01.036. Epub 2018 Feb 21.

26.

[Pathogenesis of atopic dermatitis].

Scheerer C, Eyerich K.

Hautarzt. 2018 Mar;69(3):191-196. doi: 10.1007/s00105-018-4127-4. Review. German.

PMID:
29404622
27.

Rezidivierende Ohrschwellung.

Chylla R, Hein R, Biedermann T, Eyerich K.

J Dtsch Dermatol Ges. 2018 Jan;16(1):96-98. doi: 10.1111/ddg.13399_g. No abstract available.

PMID:
29314682
28.

Recurrent swelling of the ear.

Chylla R, Hein R, Biedermann T, Eyerich K.

J Dtsch Dermatol Ges. 2018 Jan;16(1):96-98. doi: 10.1111/ddg.13399. Epub 2017 Dec 20. No abstract available.

PMID:
29266874
29.

Immune response patterns in non-communicable inflammatory skin diseases.

Eyerich K, Eyerich S.

J Eur Acad Dermatol Venereol. 2018 May;32(5):692-703. doi: 10.1111/jdv.14673. Epub 2018 Jan 15. Review.

30.

STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.

Hiller J, Hagl B, Effner R, Puel A, Schaller M, Mascher B, Eyerich S, Eyerich K, Jansson AF, Ring J, Casanova JL, Renner ED, Traidl-Hoffmann C.

J Invest Dermatol. 2018 Mar;138(3):711-714. doi: 10.1016/j.jid.2017.09.035. Epub 2017 Oct 18. No abstract available.

31.

Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects.

Garzorz-Stark N, Lauffer F, Krause L, Thomas J, Atenhan A, Franz R, Roenneberg S, Boehner A, Jargosch M, Batra R, Mueller NS, Haak S, Groß C, Groß O, Traidl-Hoffmann C, Theis FJ, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K.

J Allergy Clin Immunol. 2018 Apr;141(4):1320-1333.e11. doi: 10.1016/j.jaci.2017.07.045. Epub 2017 Sep 19.

32.

Motion correction in optoacoustic mesoscopy.

Schwarz M, Garzorz-Stark N, Eyerich K, Aguirre J, Ntziachristos V.

Sci Rep. 2017 Sep 4;7(1):10386. doi: 10.1038/s41598-017-11277-y.

33.

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

Drucker AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, Spuls PI, Irvine AD, Girolomoni G, Dhar S, Flohr C, Murrell DF, Paller AS, Guttman-Yassky E.

Br J Dermatol. 2018 Mar;178(3):768-775. doi: 10.1111/bjd.15928. Epub 2018 Jan 28.

34.

Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.

Franz R, Ritter N, Hein R, Biedermann T, Al-Sisi M, Eyerich K, Garzorz-Stark N, Andres C.

Am J Dermatopathol. 2017 Oct;39(10):742-746. doi: 10.1097/DAD.0000000000000784.

PMID:
28857981
35.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
36.

Sebocytes contribute to skin inflammation by promoting the differentiation of T helper 17 cells.

Mattii M, Lovászi M, Garzorz N, Atenhan A, Quaranta M, Lauffer F, Konstantinow A, Küpper M, Zouboulis CC, Kemeny L, Eyerich K, Schmidt-Weber CB, Törőcsik D, Eyerich S.

Br J Dermatol. 2018 Mar;178(3):722-730. doi: 10.1111/bjd.15879. Epub 2018 Jan 9.

PMID:
28799643
37.

Novel key cytokines in allergy: IL-17, IL-22.

Eyerich S, Traidl-Hoffmann C, Behrendt H, Cavani A, Schmidt-Weber CB, Ring J, Eyerich K.

Allergol Select. 2017 Aug 4;1(1):71-76. doi: 10.5414/ALX01403E. eCollection 2017. Review.

38.

Sebum lipids influence macrophage polarization and activation.

Lovászi M, Mattii M, Eyerich K, Gácsi A, Csányi E, Kovács D, Rühl R, Szegedi A, Kemény L, Ståhle M, Zouboulis CC, Eyerich S, Törőcsik D.

Br J Dermatol. 2017 Dec;177(6):1671-1682. doi: 10.1111/bjd.15754. Epub 2017 Nov 28.

PMID:
28646583
39.

DMARDs in psoriasis: a critical appraisal.

Eyerich K.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):388. doi: 10.1111/jdv.14162. Review. No abstract available.

PMID:
28297165
40.

IL-17 and IL-22 in immunity: Driving protection and pathology.

Eyerich K, Dimartino V, Cavani A.

Eur J Immunol. 2017 Apr;47(4):607-614. doi: 10.1002/eji.201646723. Review.

41.

Addiction: an underestimated problem in psoriasis health care.

Zink A, Herrmann M, Fischer T, Lauffer F, Garzorz-Stark N, Böhner A, Spinner CD, Biedermann T, Eyerich K.

J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1308-1315. doi: 10.1111/jdv.14204. Epub 2017 Mar 31.

PMID:
28281329
42.
43.

Skin symptoms as diagnostic clue for autoinflammatory diseases.

Moreira A, Torres B, Peruzzo J, Mota A, Eyerich K, Ring J.

An Bras Dermatol. 2017 Jan-Feb;92(1):72-80. doi: 10.1590/abd1806-4841.20175208. Review.

44.

Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, Luger TA, Deleuran M, Werfel T, Eyerich K, Stingl G; Councilors of the International Eczema Council.

J Invest Dermatol. 2017 Jan;137(1):18-25. doi: 10.1016/j.jid.2016.08.022. Epub 2016 Oct 20. Review.

45.

[Diabetes and skin].

de Béchade T, Eyerich K.

MMW Fortschr Med. 2016 Sep;158(15):55-60. doi: 10.1007/s15006-016-8663-5. Review. German. No abstract available.

PMID:
27596197
46.

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA.

J Allergy Clin Immunol. 2016 Aug;138(2):336-49. doi: 10.1016/j.jaci.2016.06.010. Review.

PMID:
27497276
47.

A novel molecular disease classifier for psoriasis and eczema.

Garzorz-Stark N, Krause L, Lauffer F, Atenhan A, Thomas J, Stark SP, Franz R, Weidinger S, Balato A, Mueller NS, Theis FJ, Ring J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K.

Exp Dermatol. 2016 Oct;25(10):767-74. doi: 10.1111/exd.13077.

PMID:
27193975
48.

Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine.

Bieber T, Akdis C, Lauener R, Traidl-Hoffmann C, Schmid-Grendelmeier P, Schäppi G, Allam JP, Apfelbacher C, Augustin M, Beck L, Biedermann T, Braun-Fahrländer C, Chew FT, Clavel T, Crameri R, Darsow U, Deleuran M, Dittlein D, Duchna HW, Eichenfeld L, Eyerich K, Frei R, Gelmetti C, Gieler U, Gilles S, Glatz M, Grando K, Green J, Gutermuth J, Guttman-Yassky E, Hanifin J, Hijnen D, Hoetzenecker W, Irvine A, Kalweit A, Katoh N, Knol E, Koren H, Möhrenschlager M, Münch D, Novak N, O'Mahony L, Paller AS, Rhyner C, Roduit C, Schiesser K, Schröder J, Simon D, Simon HU, Sokolowska M, Spuls P, Stalder JF, Straub D, Szalai Z, Taieb A, Takaoka R, Todd G, Todorova A, Vestergaard C, Werfel T, Wollenberg A, Ring J.

Allergy. 2016 May;71(5):588-92. doi: 10.1111/all.12857. Epub 2016 Mar 8. No abstract available.

PMID:
27023268
49.

Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donor.

Garzorz N, Thomas J, Eberlein B, Haferlach C, Ring J, Biedermann T, Schmidt-Weber C, Eyerich K, Seifert F, Eyerich S.

J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1136-9. doi: 10.1111/jdv.13617. Epub 2016 Mar 16.

PMID:
26990607
50.

Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.

Böhner A, Roenneberg S, Eyerich K, Eberlein B, Biedermann T.

JAMA Dermatol. 2016 Apr;152(4):482-4. doi: 10.1001/jamadermatol.2015.4686. No abstract available.

PMID:
26650014

Supplemental Content

Loading ...
Support Center